Duodenal mucosal resurfacing with a GLP-1 receptor agonist increases postprandial unconjugated bile acids in patients with insulin-dependent type 2 diabetes

Duodenal mucosal resurfacing (DMR) is a new endoscopic ablation technique aimed at improving glycemia and metabolic control in patients with type 2 diabetes mellitus (T2DM). DMR appears to improve insulin resistance, which is the root cause of T2DM, but its mechanism of action is largely unknown. Bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Meiring, Suzanne, Meessen, Emma C. E., van Baar, Annieke C. G., Holleman, Frits, Nieuwdorp, Max, Olde Damink, Steven W., Schaap, Frank G., Vaz, Fred M., Groen, Albert K., Soeters, Maarten R., Bergman, Jacques J. G. H. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Physiological Society 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858668/
https://www.ncbi.nlm.nih.gov/pubmed/34957857
http://dx.doi.org/10.1152/ajpendo.00337.2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858668/
https://www.ncbi.nlm.nih.gov/pubmed/34957857
http://dx.doi.org/10.1152/ajpendo.00337.2021

Ejemplares similares